Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

Cited by papers we hold 11

• The SARS‐CoV‐2 main protease (M pro ): Structure, function, and emerging therapies for COVID‐19 · 2022
  No notice
• Effects of Citrus Fruit Juices and Their Bioactive Components on Inflammation and Immunity: A Narrative Review · 2021
  No notice
• Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19 · 2021
  No notice
• Wuhan to World: The COVID-19 Pandemic · 2021
  No notice
• Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor · 2021
  No notice
• Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease · 2021
  No notice
• Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2 · 2020
  No notice
• Geographic and Genomic Distribution of SARS-CoV-2 Mutations · 2020
  No notice
• Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds · 2020
  No notice
• Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro · 2020
  No notice
• SARS-CoV-2 (COVID-19) by the numbers · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.